TNFSF4 antibody (APC)

Catalog No. ABIN594139

This Mouse Monoclonal antibody specifically detects TNFSF4 in FACS. It exhibits reactivity toward Human.

Quick Overview for TNFSF4 antibody (APC) (ABIN594139)

Target: TNFSF4 (Tumor Necrosis Factor (Ligand) Superfamily, Member 4 (TNFSF4))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This TNFSF4 antibody is conjugated to APC

Application: Flow Cytometry (FACS)

Product Details anti-TNFSF4 Antibody (APC)

Specificity: Recognizes human OX40.

Purification: Protein G purified

Immunogen: NS0-derived, recombinant human OX40 Ligand.

Isotype: IgG1

Application Details

Application Notes: Approved: Flo

Usage: Suitable for use in Flow Cytometry. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: Supplied as a liquid in saline, 0.5 % BSA, 0.09 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Aliquot to Avoid repeated freezing and thawing.

Storage: 4 °C

Storage Comment: May be stored at 4°C before opening. DO NOT FREEZE! Stable at 4°C as an undiluted liquid. Dilute only prior to immediate use. Stable for at least 1 year. Protect from light.

Target Details for TNFSF4

Target: TNFSF4 (Tumor Necrosis Factor (Ligand) Superfamily, Member 4 (TNFSF4))

Alternative Name: TNFSF4 / OX40L

Background: Name/Gene ID: TNFSF4
Family: TNF

Synonyms: TNFSF4, CD134 ligand, CD134L, CD252 antigen, Glycoprotein Gp34, OX-40L, OX40 ligand, TXGP1, OX40L, OX4OL, CD252, gp34, OX40 antigen ligand

Gene ID: 7292

UniProt: P23510

Pathways: Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation, Cancer Immune Checkpoints